Patient education: High cholesterol treatment options (Beyond the Basics)
- Robert S Rosenson, MD
Robert S Rosenson, MD
- Section Editor — Lipids
- Professor of Medicine
- Mount Sinai School of Medicine
- Director, Cardiometabolic Disorders
- Mount Sinai Heart
- Section Editor
- Mason W Freeman, MD
Mason W Freeman, MD
- Section Editor — Lipids
- Professor of Medicine
- Harvard Medical School
- Deputy Editors
- Howard Libman, MD, FACP
Howard Libman, MD, FACP
- Deputy Editor — Primary Care (Adult)
- Professor of Medicine, Emeritus
- Harvard Medical School
- Gordon M Saperia, MD, FACC
Gordon M Saperia, MD, FACC
- Senior Deputy Editor — UpToDate
- Deputy Editor — Cardiovascular Medicine
- Assistant Professor of Medicine
- Tufts University School of Medicine
High cholesterol and lipid levels can significantly increase a person's risk of developing chest pain, heart attack, and stroke. Fortunately, a number of effective treatment options are available.
Lipid levels can almost always be lowered with a combination of diet, weight loss, exercise, and medications. As lipid levels fall, so does the risk of developing cardiovascular disease (CVD), including disease of blood vessels supplying the heart (coronary artery disease), brain (cerebrovascular disease), and limbs (peripheral vascular disease). This results in a lower risk of suffering a heart attack or stroke. It is not too late if CVD is already present; lipid-lowering treatment can be lifesaving.
An explanation of what cholesterol and lipids are, how they affect health, and when levels should be measured is available in a separate topic (see "Patient education: High cholesterol and lipids (hyperlipidemia) (Beyond the Basics)"). This topic will review when treatment is recommended, the available treatment options, and the risks, benefits, and effectiveness of each treatment.
WHO NEEDS TREATMENT FOR HIGH CHOLESTEROL?
The decision to start lipid-lowering treatment is made on a case-by-case basis. Healthcare providers consider current lipid levels, the presence or absence of cardiovascular disease (CVD), and other risk factors for CVD.
People with CVD — Several large trials have demonstrated that aggressive lipid lowering is beneficial in people with coronary heart disease. Many healthcare providers recommend treating all patients with CVD with high-dose statin therapy. People who have a heart attack (myocardial infarction or MI) are started on cholesterol-lowering medication while in the hospital and are advised to make lifestyle changes, regardless of their low-density lipoprotein (LDL) cholesterol level (see "Patient education: Heart attack recovery (Beyond the Basics)"). In addition to simply placing a patient on statin therapy, some healthcare providers recommend that lipid lowering treatment achieve specific goals in patients with known CVD:
●A target LDL cholesterol level below 70 to 80 mg/dL (1.81 to 2.07 mmol/L) is recommended for people who have CVD and have multiple major risk factors (eg, people with diabetes or who smoke).
●A target LDL cholesterol level less than 100 mg/dL (2.59 mmol/L) is recommended for people who have CVD but do not have many additional risk factors. Lifestyle changes as well as nonstatin medications may be recommended when LDL cholesterol levels are higher than 100 mg/dL (2.59 mmol/L).
These general guidelines may be modified by other individual factors.
People without CVD — People without a history of CVD also appear to benefit from lipid lowering therapy, although the treatments are not as aggressive as in patients with CVD. Many experts make recommendations, based on the global risk of developing CVD as predicted by as risk calculator (see "Patient education: High cholesterol and lipids (hyperlipidemia) (Beyond the Basics)", section on 'Calculating risk'). Some clinicians recommend treatment at a particular level of risk (such as a 7.5 percent or 10 percent risk of developing CVD over 10 years), while others may focus more on your individual preferences for taking medications to reduce risk. In either case, as with patients with CVD, when a medication is prescribed the initial choice is almost always a statin.
Other special groups
Hypertriglyceridemia — High triglycerides have not generally been thought to pose the same risk of CHD as LDL cholesterol. However, healthcare providers often recommend treatment for people with elevated triglyceride levels if they:
●Have very high levels (>500 to 1000 mg/dL or 5.65 to 11.3 mmol/L)
●Also have high LDL cholesterol or low HDL cholesterol levels
●Have a strong family history of CHD
●Have other risk factors for CHD
Diabetes mellitus — People with diabetes (type 1 or 2) are at high risk of heart disease. Thus, an LDL level below 100 mg/dL (2.59 mmol/L) is recommended in many people with diabetes. (See "Patient education: Diabetes mellitus type 2: Overview (Beyond the Basics)".)
Elderly — The decision to treat high cholesterol levels in an elderly person depends upon the individual's chronologic age (age in years) and physiologic age (health, fitness). A person with a limited life span and underlying illness is probably not a good candidate for drug therapy. On the other hand, an otherwise healthy elderly person should not be denied drug therapy simply on the basis of age alone. In general, the treatment goals discussed above are followed for elderly people.
HIGH CHOLESTEROL TREATMENT OPTIONS
Lipid levels can be lowered with lifestyle changes, medications, or a combination of these approaches. In certain cases, a healthcare provider will recommend a trial of lifestyle changes before recommending a medication. The best approach for you will depend on your individual situation, including your lipid levels, health conditions, risk factors, medications, and lifestyle.
Lifestyle changes — All patients with high low-density lipoprotein (LDL) cholesterol should try to make some changes in their day-to-day habits, by reducing total and saturated fat in the diet, losing weight (if overweight or obese), performing aerobic exercise, and eating a diet rich in fruits and vegetables. (See "Patient education: Exercise (Beyond the Basics)" and "Patient education: Diet and health (Beyond the Basics)".)
The benefits of such lifestyle modifications usually become evident within 6 to 12 months. However, the success of lipid lowering with lifestyle modification varies widely, and healthcare providers sometimes elect to begin drug therapy before this time period is over.
Medications — There are many medications available to help lower elevated levels of LDL cholesterol and triglycerides, but only a few for increasing HDL cholesterol. Each category of medication targets a specific lipid and varies in how it works, how effective it is, and how much it costs. Your healthcare provider will recommend a medication or combination of medications based on blood lipid levels and other individual factors.
Statins — Statins are among the most powerful drugs for lowering LDL cholesterol and are the most effective drugs for prevention of coronary heart disease, heart attack, stroke, and death. Statins include lovastatin, pravastatin, simvastatin, fluvastatin, atorvastatin, and rosuvastatin (table 1). These medications decrease the body's production of cholesterol and can reduce LDL levels by as much as 20 to 60 percent. In addition, statins can lower triglycerides and slightly raise HDL cholesterol levels. Statins may prevent heart attacks and strokes in more ways than just lowering cholesterol levels. For instance, statins seem to help keep buildups in blood vessels (known as plaques) from rupturing. Plaque rupture is an important event that can lead to a heart attack.
It is important to closely follow the dosing instructions for when to take statins; some are more effective when taken before bedtime while others should be taken with a meal.
In addition, some foods, such as grapefruit or grapefruit juice, can increase the risk of side effects of statins. Most manufacturers recommend that people who take lovastatin, simvastatin, or atorvastatin consume no more than one-half of a grapefruit or 8 ounces of grapefruit juice per day.
PCSK9 inhibitors — PCSK9 inhibitors are a newer class of drug that lower LDL cholesterol levels. Drugs in this class also lower levels of other lipoproteins, such as lipoprotein(a), that can cause buildup of blood vessel plaques. The PCSK9 inhibitors include alirocumab and evolocumab (table 1), which are given by injection every two to four weeks. They reduce LDL cholesterol by as much as 60 to 70 percent. While experience with these drugs is growing, more study is needed to understand the longer-term effects. It appears that they can substantially reduce cardiovascular events (such as heart attack or stroke) and potentially death. Aside from mild skin reactions at the site of injection, they are well tolerated.
Ezetimibe — Ezetimibe (brand name: Zetia) impairs the body's ability to absorb cholesterol from food as well as cholesterol that the body produces internally. It lowers LDL cholesterol levels and has relatively few side effects. When used in combination with a statin in treatment after an acute coronary syndrome (eg, heart attack), ezetimibe provides a small additional reduction in cardiovascular events.
Bile acid sequestrants — The bile acid sequestrants include cholestyramine, colestipol, and colesevelam (table 1). These medications bind to bile acids in the intestine, reducing the amount of cholesterol absorbed from foods.
Bile acid sequestrants may be recommended to treat mild to moderately elevated LDL cholesterol levels. However, side effects can be bothersome, and may include nausea, bloating, cramping, and liver injury. Taking psyllium (a fiber supplement, such as Metamucil) can sometimes reduce the dose required and the side effects.
Bile acid sequestrants can interact with some medications, including as digoxin (brand name: Lanoxin) and warfarin (brand name: Coumadin), and with the absorption of fat-soluble vitamins (including vitamins A, D, K, and E). Taking these medications at different times of day can solve these problems in some cases.
Nicotinic acid (Niacin) — Nicotinic acid is a vitamin that is available in immediate-release, sustained-release, and extended-release formulations (table 1). Nicotinic acid may be recommended for people with elevated cholesterol levels that do not respond adequately despite maximum tolerated dosages of statins and for people with some types of familial hyperlipidemia, particularly those with high lipoprotein(a) levels. However, most patients taking statins should not take nicotinic acid.
●Side effects – Nicotinic acid has several possible side effects, including flushing (when the face or body turns red and becomes warm), itching, nausea, and numbness and tingling. This medication can also injure the liver; patients who use it require regular monitoring of liver function.
Taking nicotinic acid with food and taking aspirin (325 to 650 mg) 30 minutes before can decrease the side effects. Side effects often improve after 7 to 10 days. The immediate-release formulation is more likely to produce side effects, but is also more effective at lowering cholesterol levels and less likely to injure the liver than certain sustained-release formulations. The sustained-release and extended-release formulations have fewer side effects. Nicotinic acid should be taken with food or shortly after ingesting the largest meal of the day.
Nicotinic acid can produce other side effects in some people. For example, it can blunt the body's reaction to insulin, which can increase blood sugar levels in diabetics. It can increase uric acid levels in people with gout and is not recommended for this group. Nicotinic acid can also produce low blood pressure in people taking vasodilator medications such as nitroglycerin, and it can sometimes worsen angina pectoris (chest pain). Nicotinic acid can also increase the risk of developing infections and bleeding.
Fibrates — Fibrate medications (gemfibrozil, fenofibrate and fenofibric acid) can lower triglyceride levels and raise HDL cholesterol levels (table 1).
Fibrates may be recommended for people with elevated triglyceride and cholesterol levels. Fibrates have been associated with muscle toxicity (causing muscle pain or weakness), especially when used by people with kidney insufficiency or when used in combination with a statin medication. Fenofibrate/fenofibric acid (brand names: Tricor, Triglide, Trilipex) are less likely to interact with statins than gemfibrozil, and are safer in people who must use both medications.
Fish oil — Oily fish, such as mackerel, herring, bluefish, sardines, salmon, and anchovies, contain two important fatty acids, called DHA and EPA. Eating a diet that includes one to two servings of oily fish per week can reduce triglyceride levels and reduce the risk of death from coronary heart disease. Fish oil supplements are believed to have the same benefit. A daily 1 gram fish oil supplement may be recommended if you do not eat enough fish.
Soy protein — Soy protein contains isoflavones, which mimic the action of estrogen. A diet high in soy protein can slightly lower levels of total cholesterol, LDL cholesterol, and triglycerides, and raise levels of HDL cholesterol. However, normal protein should not be replaced with soy protein or isoflavone supplements in an effort to lower cholesterol levels.
Soy foods and food products (eg, tofu, soy butter, edamame, some soy burgers, etc.) are likely to have beneficial effects on lipids and cardiovascular health because they are low in saturated fats and high in unsaturated fats.
Garlic — A large trial showed that garlic is not effective in lowering cholesterol . In this study, participants with an elevated LDL took one of several types of garlic extract (raw, powdered, aged) or a placebo (inactive pill) six days per week for six months. At the end of the study, the LDL levels were not improved in the garlic group compared to the group that took the placebo. We do not recommend garlic to lower cholesterol.
Plant stanols and sterols — Plant stanols and sterols may act by blocking the absorption of cholesterol in the intestine. They are naturally found in some fruits, vegetables, vegetable oils, nuts, seeds, and legumes. They are also available in commercially prepared products such as margarine (Promise Active and Benecol), orange juice (Minute Maid Premium Heart Wise), rice milk (Rice Dream Heart Wise), as well as dietary supplements (Benecol SoftGels and Cholest-Off). The margarines cost about five times what ordinary margarines cost.
Despite lowering cholesterol levels, there are no studies demonstrating a reduced risk of coronary heart disease in people who consume supplemental plant stanols and sterols. There is some evidence that these supplements might actually increase risk.
STICKING WITH TREATMENT
The treatment of high cholesterol and/or triglycerides is a lifelong process. Although medications can rapidly lower your levels, it often takes 6 to 12 months before the effects of lifestyle modifications are noticeable. Once you have an effective treatment plan and you begin to see results, it is important to stick with the plan. Stopping treatment usually allows lipid levels to rise again.
Most people who stop treatment do so because of side effects. However, there are a wide variety of medications available today, which should make it possible for most people to find an option that works for them. Talk with a healthcare provider if a specific medication is not working; he or she can recommend alternatives that are compatible with your lifestyle and beliefs.
WHERE TO GET MORE INFORMATION
Your healthcare provider is the best source of information for questions and concerns related to your medical problem.
This article will be updated as needed on our web site (www.uptodate.com/patients). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.
Patient level information — UpToDate offers two types of patient education materials.
The Basics — The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.
Beyond the Basics — Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.
Patient education: High cholesterol and lipids (hyperlipidemia) (Beyond the Basics)
Patient education: Heart attack recovery (Beyond the Basics)
Patient education: Diabetes mellitus type 2: Overview (Beyond the Basics)
Patient education: Exercise (Beyond the Basics)
Patient education: Diet and health (Beyond the Basics)
Professional level information — Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.
Low density lipoprotein-cholesterol (LDL-C) lowering after an acute coronary syndrome
HDL cholesterol: Clinical aspects of abnormal values
Lipid abnormalities after cardiac transplantation
Lipid abnormalities after renal transplantation
Lipid abnormalities in thyroid disease
Lipid lowering with diet or dietary supplements
Low density lipoprotein cholesterol lowering with drugs other than statins and PCSK9 inhibitors
Lipoprotein classification, metabolism, and role in atherosclerosis
Lipoprotein(a) and cardiovascular disease
Management of cardiovascular risk (including dyslipidemia) in the HIV-infected patient
Measurement of blood lipids and lipoproteins
Mechanisms of benefit of lipid-lowering drugs in patients with coronary heart disease
Screening for lipid disorders in adults
Statins: Actions, side effects, and administration
Treatment of drug-resistant hypercholesterolemia
Management of elevated low density lipoprotein-cholesterol (LDL-C) in primary prevention of cardiovascular disease
Management of low density lipoprotein cholesterol (LDL-C) in secondary prevention of cardiovascular disease
The following organizations also provide reliable health information.
●National Library of Medicine
●National Cholesterol Education Program of the National Heart, Lung, and Blood Institute of the NIH
●American Heart Association
●The Hormone Foundation
(www.hormone.org/questions-and-answers/2012/hyperlipidemia, available in English, Spanish, and Portuguese)
●The Framingham Heart Study
- Gardner CD, Lawson LD, Block E, et al. Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial. Arch Intern Med 2007; 167:346.
- Fedder DO, Koro CE, L'Italien GJ. New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population. Circulation 2002; 105:152.
- Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110:227.
All topics are updated as new information becomes available. Our peer review process typically takes one to six weeks depending on the issue.